Clinical Trials in Baltimore

Showing 6581-6600 of 17,842 trials

tDCS in Pediatric Acquired Brain Injury

NCT03618849

In this preliminary study, we will examine the safety, tolerability, and feasibility of transcranial direct current stimulation (tDCS), in the setting of dosage escalation, as a candidate intervention for children with Acquired Brain Injury (ABI).

Acquired Brain InjuryDisorders of Consciousness

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1 participantsStarted Aug 2019

Baltimore, Maryland, United States

TERMINATEDPhase 1< 1 mile

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

NCT01186328

An experimental drug called EZN-3042 targets survivin, a protein expressed in leukemia cells at relapse that promotes the leukemia cells to grow. The main goal of this phase I study is to find out the dose of EZN-3042 that can be safely given without serious side effects both alone and in combination with standard chemotherapy drugs during re-induction.

Lymphoblastic Leukemia, AcuteLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, T Cell+1 more

Therapeutic Advances in Childhood Leukemia Consortium6 participantsStarted Aug 2010

Los Angeles, California, United States • Baltimore, Maryland, United States • Minneapolis, Minnesota, United States +4 more locations

tDCS in Pediatric Acquired Brain Injury

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Find Trials by Condition in Baltimore

Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety

STAT: Standard Therapy Plus Active Therapy

BIO 300 Non-Small Cell Lung Cancer Study

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

ILLUMENATE Pivotal Post-Approval Study (PAS)

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Study in Subjects With Small Primary Choroidal Melanoma

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

The Acute Burn ResUscitation Multicenter Prospective Trial

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Optimizing Video Communication Assessment for Teaching Error Disclosure Skills

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma